290 related articles for article (PubMed ID: 15489655)
21. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases.
Wang TY; Chen BF; Yang YC; Chen H; Wang Y; Cviko A; Quade BJ; Sun D; Yang A; McKeon FD; Crum CP
Hum Pathol; 2001 May; 32(5):479-86. PubMed ID: 11381365
[TBL] [Abstract][Full Text] [Related]
22. Laminin 5 expression in metaplastic breast carcinomas.
Carpenter PM; Wang-Rodriguez J; Chan OT; Wilczynski SP
Am J Surg Pathol; 2008 Mar; 32(3):345-53. PubMed ID: 18300817
[TBL] [Abstract][Full Text] [Related]
23. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast.
Reis-Filho JS; Milanezi F; Paredes J; Silva P; Pereira EM; Maeda SA; de Carvalho LV; Schmitt FC
Appl Immunohistochem Mol Morphol; 2003 Mar; 11(1):1-8. PubMed ID: 12610349
[TBL] [Abstract][Full Text] [Related]
24. p63 expression is associated with high histological grade, aberrant p53 expression and TP53 mutation in HER2-positive breast carcinoma.
Guo S; Wang Y; Rohr J; Shang L; Ma J
J Clin Pathol; 2021 Oct; 74(10):641-645. PubMed ID: 32873702
[TBL] [Abstract][Full Text] [Related]
25. DeltaNp63 expression in pancreas and pancreatic neoplasia.
Basturk O; Khanani F; Sarkar F; Levi E; Cheng JD; Adsay NV
Mod Pathol; 2005 Sep; 18(9):1193-8. PubMed ID: 15976814
[TBL] [Abstract][Full Text] [Related]
26. p63 expression in epithelial ovarian tumors.
Poli Neto OB; Candido Dos Reis FJ; Zambelli Ramalho LN; Nogueira AA; de Andrade JM
Int J Gynecol Cancer; 2006; 16(1):152-5. PubMed ID: 16445626
[TBL] [Abstract][Full Text] [Related]
27. GATA binding protein 3 (GATA3) as a marker for metaplastic spindle cell carcinoma of the breast.
Jin C; Hacking S; Sajjan S; Kamanda S; Bhuiya T; Nasim M
Pathol Res Pract; 2021 May; 221():153413. PubMed ID: 33770555
[TBL] [Abstract][Full Text] [Related]
28. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.
Leibl S; Gogg-Kammerer M; Sommersacher A; Denk H; Moinfar F
Am J Surg Pathol; 2005 Mar; 29(3):347-53. PubMed ID: 15725803
[TBL] [Abstract][Full Text] [Related]
29. p63 expression in sarcomatoid/metaplastic carcinomas of the breast.
Reis-Filho JS; Schmitt FC
Histopathology; 2003 Jan; 42(1):94-5. PubMed ID: 12493033
[No Abstract] [Full Text] [Related]
30. Elevated expression of p63 protein in human esophageal squamous cell carcinomas.
Hu H; Xia SH; Li AD; Xu X; Cai Y; Han YL; Wei F; Chen BS; Huang XP; Han YS; Zhang JW; Zhang X; Wu M; Wang MR
Int J Cancer; 2002 Dec; 102(6):580-3. PubMed ID: 12447998
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of GLUT1, p63 and phosphorylated histone H1 in head and neck squamous intraepithelial neoplasia: evidence for aberrations in hypoxia-related, cell cycle- and stem-cell-regulatory pathways.
Burstein DE; Nagi C; Kohtz DS; Lumerman H; Wang BY
Histopathology; 2006 May; 48(6):708-16. PubMed ID: 16681687
[TBL] [Abstract][Full Text] [Related]
33. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
34. Keratin Expression Patterns in Stromal Cells of Benign Sclerosing Lesions of the Breast: A Potential Diagnostic Pitfall.
Oh EY; Collins LC
Arch Pathol Lab Med; 2015 Sep; 139(9):1143-8. PubMed ID: 25989286
[TBL] [Abstract][Full Text] [Related]
35. P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression.
Preto A; Reis-Filho JS; Ricardo S; Soares P
Pathol Res Pract; 2002; 198(7):449-54. PubMed ID: 12234063
[TBL] [Abstract][Full Text] [Related]
36. p63 and CD10: reliable markers in discriminating benign sclerosing lesions from tubular carcinoma of the breast?
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Alvarenga M; Vassallo J
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):71-7. PubMed ID: 16540734
[TBL] [Abstract][Full Text] [Related]
37. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.
Leibl S; Moinfar F
Am J Surg Pathol; 2006 Apr; 30(4):450-6. PubMed ID: 16625090
[TBL] [Abstract][Full Text] [Related]
38. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
[TBL] [Abstract][Full Text] [Related]
39. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
[TBL] [Abstract][Full Text] [Related]
40. p63 expression profiles in human normal and tumor tissues.
Di Como CJ; Urist MJ; Babayan I; Drobnjak M; Hedvat CV; Teruya-Feldstein J; Pohar K; Hoos A; Cordon-Cardo C
Clin Cancer Res; 2002 Feb; 8(2):494-501. PubMed ID: 11839669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
